Process for bacterial production of polypeptides

• US 5,789,199 A
• Filed: 10/31/1996
• Issued: 08/04/1998
• Est. Priority Date: 11/03/1994
• Status: Expired due to Term

• Current Assignee: Genentech, Inc. (Roche Holding AG)
• Original Assignee: Genentech, Inc. (Roche Holding AG)
• Inventors: Joly, John C., Swartz, James R.
• Primary Examiner(s): Kemmerer, Elizabeth C.
• Assistant Examiner(s): Lathrop, Brian
• Application Number:
  US08/741,727
• Time in Patent Office: 642 Days
• Field of Search: 435/69.1, 435/252.3, 435/252.33, 935/11, 935/43
• US Class Current: 435/69.1
• CPC Class Codes: C07K 1/1133 by redox-reactions involving cystein/cystin side chains
• CPC Class Codes: C07K 14/245 Escherichia (G)
• CPC Class Codes: C07K 14/65 Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
• CPC Class Codes: C07K 2319/00 Fusion polypeptide
• CPC Class Codes: C12N 15/70 Vectors or expression systems specially adapted for E. coli
• CPC Class Codes: C12N 9/0051 acting on a sulfur group of donors (1.8)
• CPC Class Codes: C12N 9/90 Isomerases (5.)
• CPC Class Codes: C12P 21/02 having a known sequence of two or more amino acids, e.g. glutathione

Abstract

A process is provided for producing a heterologous polypeptide in bacteria. This process comprises, in a first step, culturing bacterial cells that lack their native pstS gene and comprise nucleic acid encoding a PstS variant having an amino acid variation within the phosphate-binding region of the corresponding native PstS, nucleic acid encoding a DsbA or DsbC protein, nucleic acid encoding the heterologous polypeptide, a signal sequence for secretion of both the DsbA or DsbC protein and the heterologous polypeptide, an inducible promoter for the nucleic acid encoding the DsbA or DsbC protein, and an alkaline phosphatase promoter for the nucleic acid encoding the heterologous polypeptide. The nucleic acid encoding a PstS variant is under the transcriptional control of the wild-type pstS gene promoter. The second step of the process involves recovering the heterologous polypeptide from the periplasm or the culture medium.

Claims

1. A process for producing a heterologous polypeptide in bacteria comprising:

(a) culturing bacterial cells that lack their native pstS gene and comprise nucleic acid encoding a PstS variant having an amino acid variation within the phosphate-binding region of the corresponding native PstS, nucleic acid encoding a DsbA or DsbC protein, nucleic acid encoding the heterologous polypeptide, a signal sequence for secretion of both the DsbA or DsbC protein and the heterologous polypeptide, an inducible promoter for the nucleic acid encoding the DsbA or DsbC protein, and an alkaline phosphatase promoter for the nucleic acid encoding the heterologous polypeptide, wherein the nucleic acid encoding a PstS variant is under the transcriptional control of the wild-type pstS gene promoter, and wherein the culturing takes place under conditions whereby expression of the nucleic acid encoding the DsbA or DsbC protein is induced prior to induction of the expression of the nucleic acid encoding the heterologous polypeptide, under conditions whereby the culturing takes place in a culture medium at a concentration of inorganic phosphate in the medium that during all phases of cell growth is above the level at which the cells are starved for phosphate, and under conditions whereby either both the heterologous polypeptide and the DsbA or DsbC protein are secreted into the periplasm of the bacteria or the heterologous polypeptide is secreted into the medium in which the bacterial cells are cultured; and

(b) recovering the heterologous polypeptide from the periplasm or the culture medium.

2. The process of claim 1 wherein the heterologous polypeptide is a mammalian polypeptide.

3. The process of claim 2 wherein the mammalian polypeptide is a human polypeptide.

4. The process of claim 3 wherein the human polypeptide is insulin-like growth factor-I.

5. The process of claim 1 wherein the concentration of inorganic phosphate at all phases of cell growth is more than about 0.5 mM and wherein the pstS variant is homologous to the native pstS gene in the host cells.

6. The process of claim 1 wherein the heterologous is recovered from the periplasm of the bacterial cells.

7. The process of claim 1 wherein the bacterial cells are Enterobacteriaceae cells.

8. The process of claim 1 wherein the amino acid variation in the nucleic acid molecule is an amino acid substitution.

9. The process of claim 8 wherein the bacterial cells are E. coli and a hydrophobic residue is substituted for threonine at position 10 of-the phosphate-binding region of native E. coli PstS.

10. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes T10F PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

11. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes T10L PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

12. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes T10M PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

13. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes T10Y PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

14. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes T10A PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

15. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes T10C PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

16. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes T10G PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

17. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes S38F PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

18. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes D56V PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

19. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes D56A PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

20. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes D56L PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

21. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes D56S PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

22. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes S139T PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

23. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes S139P PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

24. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes S139L PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

25. The process of claim 8 wherein the nucleic acid encoding a PstS variant encodes T141H PstS under the transcriptional control of the wild-type E. coli pstS gene promoter.

26. The process of claim 1 wherein the nucleic acid encoding the PstS variant is integrated into the chromosome thereof.

27. The process of claim 1 wherein nucleic acid encoding DsbA is expressed.

28. The process of claim 1 wherein after the polypeptide is recovered, the DsbA or DsbC protein is separated from the polypeptide.

29. The process of claim 1 wherein the bacterial cells are transformed with one or two expression vectors containing the nucleic acid encoding the DsbA or DsbC protein and the nucleic acid encoding the heterologous polypeptide.

30. The process of claim 29 wherein the bacterial cells are transformed with two vectors respectively containing the nucleic acid encoding the DsbA or DsbC protein and the nucleic acid encoding the heterologous polypeptide.

31. The process of claim 29 wherein the nucleic acid encoding the DsbA or DsbC protein and the nucleic acid encoding the heterologous polypeptide are contained on one vector with which the bacterial cells are transformed.

32. The process of claim 1 wherein the induction of expression of the nucleic acid encoding DsbA or DsbC is carried out by adding an inducer to the culture medium.